Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2000;36:291-295

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, A.
Right arrow Articles by Keaney, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, A.
Right arrow Articles by Keaney, J. F., Jr
Related Collections
Right arrow Hypertension - basic studies
Right arrow Coronary circulation
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2000;36:291.)
© 2000 American Heart Association, Inc.


Scientific Contributions

Ascorbic Acid and Glutathione Modulate the Biological Activity of S-Nitrosoglutathione

Aiming Xu; Joseph A. Vita; John F. Keaney, Jr

From the Evans Memorial Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.

Correspondence to Dr John F. Keaney, Jr, Whitaker Cardiovascular Institute, Boston University School of Medicine, 80 E Concord St, Room W507, Boston, MA 02118. E-mail jkeaney{at}bu.edu

Abstract—Ascorbic acid and glutathione (GSH) are important determinants of the intracellular redox state, and both are known to accelerate the decomposition of S-nitrosoglutathione (GSNO), an endogenous adduct of nitric oxide (NO). The implications of these observations for GSNO bioactivity are not yet clear. We investigated the effect of ascorbic acid and GSH on GSNO bioactivity by using a bioassay with isolated segments of guinea pig aorta suspended in organ chambers. Arterial segments demonstrated relaxation to GSNO (0.1 µmol/L) that was significantly enhanced by 300 µmol/L ascorbic acid (71±6% versus 53±6%, P<0.05) but not GSH. Both ascorbic acid and GSH significantly shortened the duration of arterial relaxation in response to 0.1 µmol/L GSNO (from >120 minutes to 22.5±3.5 and 36.3±4.3 minutes, respectively; P<0.05), consistent with accelerated decomposition of GSNO that was confirmed spectrophotometrically. The effect of ascorbic acid was abrogated by either DTPA or the copper(I)-specific agent bathocuproine but not deferoxamine, indicating a dependence on the availability of redox-active copper. Consistent with this notion, the action of ascorbic acid on GSNO bioactivity was also supported by copper-zinc superoxide dismutase, a physiologically relevant source of copper. In contrast, the effect of GSH on GSNO degradation and GSNO-mediated arterial relaxation was independent of transition metal ions, because DTPA had no effect. These data indicate that both ascorbic acid and GSH modulate GSNO bioactivity and suggest a distinction between the mechanism of GSNO degradation by ascorbic acid or GSH. Whereas both ascorbic acid and GSH accelerate the degradation of GSNO, only ascorbic acid is dependent on the presence of transition metal ions.


Key Words: antioxidants • oxidation-reduction • blood vessels • nitric oxide • S-nitrosoglutathione • relaxation




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
S. Nambiar, S. Viswanathan, B. Zachariah, N. Hanumanthappa, and Sridhar Gopalakrishna Magadi
Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials
Angiology, April 1, 2009; 60(2): 221 - 234.
[Abstract] [PDF]


Home page
HypertensionHome page
S. Ulker, P. P. McKeown, and U. Bayraktutan
Vitamins Reverse Endothelial Dysfunction Through Regulation of eNOS and NAD(P)H Oxidase Activities
Hypertension, March 1, 2003; 41(3): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D C Chambers and J G Ayres
Effects of nitrogen dioxide exposure and ascorbic acid supplementation on exhaled nitric oxide in healthy human subjects
Thorax, October 1, 2001; 56(10): 774 - 778.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Chen, R. M. Touyz, J. B. Park, and E. L. Schiffrin
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR
Hypertension, September 1, 2001; 38(3): 606 - 611.
[Abstract] [Full Text] [PDF]